A Pilot Study Assessing Myokines During an EXErcise Regimen After Treatment for Breast Cancer

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-89
SponsorAllegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)

About this trial

In this pilot study, the investigators will assess the changes in myokine production based on several different exercise regimens.

Eligibility criteria

Qualifiers

Age 20-89 years

Women prescribed exercise as a SOC

Women with a biopsy proven diagnosis of ductal carcinoma in situ (DCIS) or invasive carcinoma of the breast

Women must have undergone treatment for breast cancer, including one or more of the following: surgery, radiation therapy, chemotherapy, immunotherapy, or hormonal therapy. Women undergoing active chemotherapy are not allowed on study. Immunotherapy or targeted agent usage is allowed.

Disqualifiers

Any current treatment with cytotoxic chemotherapy for breast cancer

Inability to safely engage in group sessions of resistance training as deemed by study PI

Severe arthritic, joint, cardiovascular, or musculoskeletal condition deemed by PI to be unsafe to engage in resistance training

Pregnant women

Trial design

Treatments tested in this trial

  • Conditioning Resistance Training
  • Strength Resistance Training
  • Hypertrophy Resistance Training

Treatment groups

21 Participants
are divided into 3 treatment groups